In comparison to the funding and survival rate of many other cancer types, funding for ovarian, cervical, and uterine cancer does not align with their survival rates.
This finding was presented at the Society of Gynecologic Oncology’s (SGO) 2018 Annual Meeting on Women’s Cancer (March 24-27; New Orleans, LA).
Researchers from the University of Wisconsin School of Medicine and Public Health ad well as the University of Michigan Health Systems conducted a study to analyze funding distributions from the National Cancer Institute (NCI) to gynecologic cancers compared with other cancer types from 2007 through 2014. Researchers calculated a score for the funding received per years of life lost from 100 incident cases of uterine, ovarian, and cervix cancer standardized for mortality and incidence by utilizing the NCI’s Surveillance, Epidemiology, and End Results (SEER) Cancer Trends Progress Report and Funding Statistics.
Read the full article at: https://www.journalofclinicalpathways.com/news/gynecologic-cancers-significantly-underfunded-compared-other-cancers